Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rules-Based Medicine provides CLIA-certified multiplexed immunoassay services supporting drug development with quantitative data on hundreds of proteins. Their platforms are used in both research and clinical settings to advance biomarker discovery—especially in neurology—and to enable early detection/diagnosis of complex diseases. They have supported large-scale studies including those related to Alzheimer’s Disease Neuroimaging Initiative.
Their initial molecular diagnostic test VeriPsych aids diagnosis of recent-onset schizophrenia using a proprietary set of biomarkers.
The company has processed thousands of samples from major academic consortia.
No therapeutics developed or marketed.
Pipeline breadth/pipeline fields below reflect diagnostics/services rather than drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rules-Based Medicine.